Navigation Links
Venture Capital Veteran John Brooks Joins Life Science Investment Bank Johnston Blakely & Company
Date:5/4/2009

BOSTON, May 4 /PRNewswire/ -- Johnston Blakely & Company, LLC, a Boston-based life science investment bank, is pleased to announce that John L. Brooks, III has joined the firm as senior advisor. In this role, Mr. Brooks will participate with the firm on internal and client-related activities including private equity placements and merger & acquisition advisory services, with a particular focus on medical device transactions. "We are thrilled to welcome John Brooks to the Johnston Blakely family," remarked Johnston Blakely founder Benjamin Conway. "Not only does John bring to the firm and its clients a track record of success in both venture capital and the medical device industry, but his decision to join us is also a strong endorsement of Johnston Blakely and its capabilities."

John Brooks co-founded the venture capital firm Prism Venture Partners. During his ten-year tenure with Prism, the firm raised $1.25 billion across six venture funds. While with Prism, Mr. Brooks led the firm's healthcare investment activities including its role in the creation of companies such as Insulet Corporation. His previous experience also includes senior management positions at Pfizer, both with Pfizer/Valleylab as General Manager and with Pfizer/Strato. Mr. Brooks has held several vice president of finance and operations positions at successful venture-backed companies and spent over 10 years in public accounting and consulting focused on supporting venture backed entrepreneurs.

In addition to his current involvement on the boards of certain Prism portfolio companies, John Brooks is vice chairman of the Board of Trustees of the Joslin Diabetes Center where he is also chairman of the finance committee, a member of the steering committee of Mass Medic's MedTech Ignite (Inspiring Growth in New Innovative Technology Enterprises) program and is on the Draper BioAdvisory Board.

About Johnston Blakely &
'/>"/>

SOURCE Johnston Blakely & Company, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. UMass Boston Opens Venture Development Center to Expand R&D Activity
2. Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities
3. Merck Engages PharmaVentures to Assist in the Divestment of its Italian Research Centre IRBM
4. CTI Receives the Second Payment of $6.5 million Associated with the Sale of Interest in Zevalin Joint Venture
5. NexGen Biofuels Ltd Signs Letter of Intent for the Purchase of World Venture Management, Inc. Assets and the Sale of its Current Business
6. Cynvec to Present at the BIO National Venture Conference
7. Horizon Therapeutics Selected to Present at InsideVentures Debut Investor Conference March 25-26, Santa Barbara, California
8. Merck Serono Launches Strategic Venture Capital Fund
9. StartUpHire Launches Comprehensive Search Engine for Jobs at Venture-Backed Companies
10. Jina Ventures Advises Swiss Pharma Contract on Strategic Sale to Covance Inc
11. Alltech, Mitsui and Asahi Breweries Create New Venture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... N.J. , March 30, 2015  Naldemedine, ... under development by Shionogi & Co., Ltd., met ... III study (COMPOSE I) for the treatment of ... non-cancer pain receiving opioid therapy. Study results showed ... statistically significantly improved the frequency of spontaneous bowel ...
(Date:3/29/2015)... IRVING, Texas , March 29, 2015 /PRNewswire/ ... two studies in which Caris Molecular Intelligence®, the ... molecular similarities and differences between several rare and ... treatment strategies that have the potential to improve ... Poster Session B at the Society of Gynecologic ...
(Date:3/29/2015)... As a symbol of its commitment ... pharmaceutical manufacturing clients, Whitehouse Laboratories is excited to announce ... Race Team for the 2015 race season. Success on ... a strong sense of precision and attention to detail. ... in the quality control testing laboratory. Sponsorship of the ...
(Date:3/27/2015)... , 27. März 2015  Peter Walter ... Biomedical Science für seine bahnbrechende Arbeit ausgewählt, ... Zellkompartimenten transportiert werden, sowie für die Entschlüsselung ... Reaktion auf Stress nutzen, der mit der ... ist Professor für Biochemie an der University ...
Breaking Biology Technology:Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 2Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 3Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 4Whitehouse Laboratories Reaffirms Commitment to Speedy Results – Renews Sponsorship of Berkenstock Racing Team 2Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 2Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 3Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 4
... Conn. Two major steps toward putting quantum computers into ... a qubit onto wires and transmitting the signal to a ... team of scientists at Yale. The accomplishments are reported in ... on which it is highlighted as the cover along with ...
... (Nasdaq: PRXL ), a leading global ... of the acquisition,of Taiwan-based APEX International Clinical ... release. In conjunction with the acquisition and ... its forward-looking,financial guidance for the first quarter ...
... 26 Today at the Clinton Global,Initiative ... a,ground-breaking vaccine to eliminate epidemic meningitis in ... developed by the Meningitis,Vaccine Project, a partnership ... produced by Serum Institute of India Limited ...
Cached Biology Technology:Yale scientists make 2 giant steps in advancement of quantum computing 2Yale scientists make 2 giant steps in advancement of quantum computing 3PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors 2PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors 3PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors 4PATH, World Health Organization, and Partners Introduce Meningitis Vaccine in Burkina Faso 2PATH, World Health Organization, and Partners Introduce Meningitis Vaccine in Burkina Faso 3
(Date:3/17/2015)... MedNet Solutions , a global ... management systems, is pleased to announce that company ... in Clinical Trials Southeast conference – March 24-25 ... forum for MedNet to showcase iMedNet , ... eClinical technology platform. We strongly encourage ...
(Date:3/12/2015)... , March 12, 2015 The mascots ... Brenner Children,s Hospital, part of Wake Forest Baptist Medical ... initiative for the 2015 ACC Men,s Basketball Tournament. Young ... with them and getting their autographs. Brenner ... Baptist. It is the only children,s hospital in northwest ...
(Date:3/10/2015)... YORK , March 10, 2015  Continuing its ... the Unexpected, Hammacher Schlemmer introduces The Eye Scanning ... identity before granting access to secure websites or sensitive ... to verify travelers at international borders, the device has ... distinctive pattern points of the iris, converting them into ...
Breaking Biology News(10 mins):Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2
... deploy a deflector shield to evade enemy attack, tumor cells ... their own to fend off treatments aimed at killing them. ... their armor. , The cells churn out an enzyme that ... damage from radiation or chemotherapy and promotes tumor cell survival. ...
... of antibodies against the Epstein-Barr virus, the virus that ... develop multiple sclerosis 15 to 20 years later, according ... in the June 2006 print issue of Archives of ... long suspected that external factors may influence the risk ...
... new way of looking beneath the ocean surface that ... , A remote sensor system developed by Associate Professor ... MIT, Northeastern University and the Naval Research Laboratory, allows ... well as small schools, over a 10,000-square-kilometer area - ...
Cached Biology News:Molecular force field helps cancer cells defend against attack 2Molecular force field helps cancer cells defend against attack 3Big hips, big belly? It's in your genes, Joslin-led study shows 2One fish, two fish: New MIT sensor improves fish counts 2
... to offer the ATTO-TAG series of ... primary amines. Developed by Novotny and ... reagents are similar to the important ... anthracene-2,3-dicarboxaldehyde, all of which are also ...
Troponin I Immunogen: Full length native protein (purified) (Human). Storage: -20 C, Avoid Freeze/Thaw Cycles...
Corticoliberin...
...
Biology Products: